shanghai zeyu experimental equipment co., ltd.-凯发app下载
in the top 10 global drug sales in 2018,
there are 8 antibody drugs, including 6 monoclonal antibody drugs, and the
total sales of 2 fusion proteins account for 76% of the top 10 total sales. six
of the eight anti-tumor drugs in the top 10 list are anti-tumor drugs (except
adalimumab and arbacip), which are mainly aimed at the hot targets such as tnf
- α, pd-1, her-2, cd20 and vegf. the anti-tumor drugs play an increasingly
important role in the field of tumor treatment.
at present, china has become the country
with the largest number of antibody drugs under research. more than 200
antibody drugs have been approved for clinical trials. some products have
completed phase iii clinical trials and submitted applications for market
registration. at present, the most popular target of antibody drug research has
been approved for listing in 9 varieties, and the products of many enterprises
are in the stage of market approval or phase iii clinical stage.
alit life science co., ltd. has been engaged
in the antibody industry for many years. it has independently developed
countstar series cell analyzers, integrated the advanced biopharmaceutical
technology in europe and the united states, and the whole process of aseptic
control solutions. it provides the international advanced high-quality and high
stability compliance instruments and technical services for the upstream and
downstream process of the antibody industry and the filling process of
preparations, so as to reduce operating costs and risks to improve the
competitiveness of the industry.
